Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PureTech Health plc (PRTC) Common Equity (2019 - 2023)

PureTech Health (PRTC) has disclosed Common Equity for 3 consecutive years, with $542.2 million as the latest value for Q4 2022.

  • On a quarterly basis, Common Equity fell 8.64% to $542.2 million in Q4 2022 year-over-year; TTM through Dec 2022 was $542.2 million, a 8.64% decrease, with the full-year FY2022 number at $542.2 million, down 8.64% from a year prior.
  • Common Equity was $542.2 million for Q4 2022 at PureTech Health, down from $593.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $669.7 million in Q4 2020 to a low of $542.2 million in Q4 2022.
  • A 3-year average of $601.8 million and a median of $593.5 million in 2021 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: fell 11.38% in 2021, then fell 8.64% in 2022.
  • PureTech Health's Common Equity stood at $669.7 million in 2020, then dropped by 11.38% to $593.5 million in 2021, then fell by 8.64% to $542.2 million in 2022.
  • Per Business Quant, the three most recent readings for PRTC's Common Equity are $542.2 million (Q4 2022), $593.5 million (Q4 2021), and $669.7 million (Q4 2020).